Keeps advertises a $49 starting offer for its TRT service. That is an entry point for evaluation, not a verified monthly price for continuing testosterone treatment. Understanding the next bill requires reading the program terms as well as the landing page.
We checked the public Keeps TRT site and its terms on September 21, 2026. This review explains the distinction between starting care, paying for continuing access, and paying for medication. We have not completed an intake, tested the service, or verified a personalized prescription price.
- The $49 offer is for starting evaluation; ongoing TRT costs are not established by it.
- Membership and medication are separate recurring charges in the terms.
- Confirm the 48-hour cancellation deadline and fulfillment restrictions.
What the starting offer says
The landing page describes the $49 offer as including bloodwork, a clinician consultation, and a personalized plan. Its process begins with testing, followed by review and medication if prescribed. That is useful information for someone comparing the cost of learning whether treatment may be appropriate, but it does not establish the total cost after evaluation.
Before starting, ask what happens if the clinician does not recommend TRT. Confirm which charges are incurred, whether any continuing enrollment begins automatically, and how results are provided to you. An evaluation can still be worthwhile when it identifies another next step; it should not be treated as a purchase that guarantees a prescription.
Two continuing charges need attention
The terms separate a Program Membership Fee from a Medication Fee. They describe membership billing every 84 days and medication billing every 12 weeks when the next supply is prepared. The document does not provide a single continuing dollar total that we can confidently attach to every reader’s plan.
Ask for both amounts and their first charge dates. Twelve weeks is not the same as three calendar months. If a quote is presented as a monthly equivalent, request the underlying billing interval before comparing it with a monthly service. The cost worksheet is most useful once you have converted each charge consistently.
Do not assume the final prescription
Keeps says medication prescribed through its affiliated clinicians has not been reviewed or approved by FDA for quality, safety, or effectiveness. Its terms discuss compounded medication. We did not verify a universal formulation, dispensing pharmacy, or dose from the public offer reviewed here, so this review does not assign a product that a reader has not actually been prescribed.
Ask for the exact medicine and why it was selected. Research about testosterone as a class does not establish the performance of every compounded finished product. The compounding guide explains that difference, including why pharmacy licensing and FDA drug approval should not be treated as synonyms.
The lab pathway offers a practical choice
Keeps describes an at-home kit or testing at a nearby Quest or Labcorp location. A reader who finds travel difficult may value that choice. Before selecting a route, confirm the test panel, specimen instructions, and whether a confirmatory blood draw could still be needed after the initial result.
A broad biomarker panel does not by itself settle a diagnosis. The Endocrine Society recommends confirmation of low testosterone with repeat morning fasting testing when evaluating deficiency. Ask how the clinic will interpret your symptoms and arrange any needed repeat measurement rather than assuming a faster collection method ends the diagnostic process.
Read cancellation before the first renewal
The terms require notice at least 48 hours before the end of the current billing cycle to avoid the next charge. They describe email cancellation and state that canceling program membership also ends the medication subscription. Medication fulfillment introduces another boundary, because the terms restrict refunds once a prescription has been written and fulfillment is underway.
There is also a conditional 90-day money-back provision tied to a specified change in total testosterone and other requirements. That is not a blanket satisfaction promise or a guarantee of symptom improvement. Read the current eligibility and claim deadlines directly; do not assume that requesting cancellation automatically triggers a refund under a separate guarantee.
Match support to the questions you expect to have
The landing page emphasizes ongoing access and reliable refills. Those are descriptions of the intended service, not response-time or delivery results we have independently measured. Ask how a clinical question is routed, how quickly the team normally responds, and what happens when a lab abnormality requires a prescription decision.
Also ask how blood pressure and blood count will be followed, and which clinician coordinates with your existing doctor. FDA’s class-wide testosterone update includes blood-pressure warnings. An online workflow can be convenient, but it still needs a practical monitoring plan and clear responsibility for decisions between refill cycles.
Our assessment of the public information
Keeps provides a defined starting offer and useful detail about billing mechanics in its terms. The central missing comparison number is the combined recurring membership and medication cost for the treatment you would receive. Until that is known, labeling the service inexpensive because of the $49 entry price would be premature.
Use the evaluation offer as one part of a larger decision. Our Keeps versus Hone comparison shows how separate medication and membership costs can affect the comparison. A written quote, the assigned prescription, and a clear cancellation date will do more for your budget than an attractive starting button.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Research checked September 21, 2026. Article updated September 21, 2026.